Cannabis use was common in both stimulant-use groups, with no significant…

Difference in Patterns of Polysubstance Use Between Adults With Primary Cocaine Versus Methamphetamine Use Disorder: Findings From NIDA CTN-0108 Study.

Substance use & addiction journal • • Related
🤖

AI Summary

This abstract-based summary describes a screening study comparing polysubstance-use patterns in 320 adults with moderate-to-severe cocaine or methamphetamine use disorder who were being assessed for a clinical trial of transcranial magnetic stimulation. Its main finding was that other substance use remained common, even though the trial excluded people with certain moderate-to-severe co-occurring substance use disorders. Alcohol use disorder was more common in the cocaine group than the methamphetamine group (21.7% vs. 8.5%).

Among participants randomized in the trial, alcohol use was also more prevalent in the cocaine group (67.9% vs. 50%), while reported cannabis use did not differ significantly between groups (50.9% vs. 46.1%; P = .6). The study reports differences between the groups and emphasizes the complexity of their substance-use profiles; it does not test cannabis as a treatment or establish that any substance use caused particular outcomes. Because this summary is based on the abstract, it cannot assess details of the full study or establish how representative the screened sample is.

💡 Key Findings

1
In this screening sample of 320 adults, polysubstance use remained prevalent despite trial exclusions for certain co-occurring moderate-to-severe substance use disorders.
High
90%
2
Alcohol use disorder was more common among participants with cocaine use disorder than among those with methamphetamine use disorder (21.7% vs. 8.5%).
High
90%
3
Reported cannabis use was similar in the cocaine and methamphetamine groups (50.9% vs. 46.1%); the abstract reports no significant difference (P = .6).
High
90%

📄 Original Abstract

BACKGROUND: Cocaine use disorder (CcUD) and methamphetamine use disorder (MtUD) are highly prevalent and associated with medical, psychiatric, and public health challenges. Polysubstance use (PSU) amplifies these risks and negatively impacts treatment outcomes. METHODS: This study compares the demographics and patterns of PSU among a sample of individuals with either moderate-to-severe CcUD or MtUD undergoing screening for a clinical trial on transcranial magnetic stimulation for the treatment of stimulant use disorder (StUD). RESULTS: Of the 320 participants screened, individuals with CcUD (N = 120) were predominantly male (83.3%) and black (72.5%), with a median age of 53.5, while those with MtUD (N = 200) were largely male (67%) and white (69%), with a median age of 41. About one third of these individuals met criteria for comorbid moderate-to-severe substance use disorder (SUD), with alcohol use disorder more common in the CcUD group (21.7% vs 8.5%, P = .0002). Despite the exclusion of participants with comorbid moderate-to-severe SUDs (other than nicotine, cocaine, and methamphetamine), PSU persisted as the dominant pattern in individuals randomized in the trial. Alcohol use remained significantly more prevalent in individuals with CcUD, reported by 67.9% versus 50% of those with MtUD (P = .048), while cannabis use was reported by 50.9% and 46.1%, respectively (P = .6). Age at initiation of primary stimulant use was similar across the CcUD and MtUD groups, while the age of first use of any substance was notably earlier. CONCLUSION: In addition to the differences noted between the CcUD and MtUD groups, these findings emphasize that despite strict inclusion criteria that excluded individuals with moderate-to-severe comorbid SUD, PSU remained highly prevalent, demonstrating a more complex clinical profile and heightened risk of adverse outcomes that should be taken into consideration when designing trials and working clinically with individuals with StUD.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.